115 related articles for article (PubMed ID: 1730596)
1. Secretion of alpha-1-proteinase inhibitor requires an almost full length molecule.
Brodbeck RM; Brown JL
J Biol Chem; 1992 Jan; 267(1):294-7. PubMed ID: 1730596
[TBL] [Abstract][Full Text] [Related]
2. Construction and expression of alpha 1-proteinase inhibitor mutants and the effects of these mutations on secretion of the variant inhibitors.
McCracken AA; Kruse KB; Valentine J; Roberts C; Yohannes TZ; Brown JL
J Biol Chem; 1991 Apr; 266(12):7578-82. PubMed ID: 2019587
[TBL] [Abstract][Full Text] [Related]
3. Study of the roles of proline 391 and a highly conserved sequence in the carboxyl-terminal region of members of the serpin family in the secretion of alpha 1-proteinase inhibitor.
Brodbeck RM; Brown JL
J Biol Chem; 1994 Jun; 269(25):17252-6. PubMed ID: 8006033
[TBL] [Abstract][Full Text] [Related]
4. Intracellular disposal of incompletely folded human alpha1-antitrypsin involves release from calnexin and post-translational trimming of asparagine-linked oligosaccharides.
Liu Y; Choudhury P; Cabral CM; Sifers RN
J Biol Chem; 1997 Mar; 272(12):7946-51. PubMed ID: 9065464
[TBL] [Abstract][Full Text] [Related]
5. A study of the effects of altering the sites for N-glycosylation in alpha-1-proteinase inhibitor variants M and S.
Samandari T; Brown JL
Protein Sci; 1993 Sep; 2(9):1400-10. PubMed ID: 8401226
[TBL] [Abstract][Full Text] [Related]
6. Accumulation of the insoluble PiZ variant of human alpha 1-antitrypsin within the hepatic endoplasmic reticulum does not elevate the steady-state level of grp78/BiP.
Graham KS; Le A; Sifers RN
J Biol Chem; 1990 Nov; 265(33):20463-8. PubMed ID: 2122976
[TBL] [Abstract][Full Text] [Related]
7. Variability in transport rates of secretory glycoproteins through the endoplasmic reticulum and Golgi in human hepatoma cells.
Yeo KT; Parent JB; Yeo TK; Olden K
J Biol Chem; 1985 Jul; 260(13):7896-902. PubMed ID: 2989265
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the properties of rare variants of alpha1-proteinase inhibitor expressed in COS-1 cells and assessment of their potential as risk factors in human disease.
Ray S; Mickleborough TD; Brown JL
Biochim Biophys Acta; 2005 Jun; 1740(3):390-402. PubMed ID: 15949707
[TBL] [Abstract][Full Text] [Related]
9. The proteasome participates in degradation of mutant alpha 1-antitrypsin Z in the endoplasmic reticulum of hepatoma-derived hepatocytes.
Teckman JH; Burrows J; Hidvegi T; Schmidt B; Hale PD; Perlmutter DH
J Biol Chem; 2001 Nov; 276(48):44865-72. PubMed ID: 11577074
[TBL] [Abstract][Full Text] [Related]
10. Association between calnexin and a secretion-incompetent variant of human alpha 1-antitrypsin.
Le A; Steiner JL; Ferrell GA; Shaker JC; Sifers RN
J Biol Chem; 1994 Mar; 269(10):7514-9. PubMed ID: 8125971
[TBL] [Abstract][Full Text] [Related]
11. alpha1-antitrypsin gene mutation hot spot associated with the formation of a retained and degraded null variant [corrected; erratum to be published].
Brantly M; Lee JH; Hildesheim J; Uhm CS; Prakash UB; Staats BA; Crystal RG; Hildeshiem J
Am J Respir Cell Mol Biol; 1997 Mar; 16(3):225-31. PubMed ID: 9070606
[TBL] [Abstract][Full Text] [Related]
12. Effects of mutations that alter the Glu264-Lys387 salt bridge on the secretion of alpha-1-proteinase inhibitor.
Brodbeck RM; Samandari T; Brown JL
J Biol Chem; 1993 Mar; 268(9):6771-6. PubMed ID: 8454649
[TBL] [Abstract][Full Text] [Related]
13. Intracellular retention and degradation of human mutant variant of a alpha 1-antitrypsin in stably transfected Chinese hamster ovary cell lines.
Ciccarelli E; Alonso MA; Cresteil D; Bollen A; Jacobs P; Alvarez F
Eur J Biochem; 1993 Apr; 213(1):271-6. PubMed ID: 8477700
[TBL] [Abstract][Full Text] [Related]
14. Soluble aggregates of the human PiZ alpha 1-antitrypsin variant are degraded within the endoplasmic reticulum by a mechanism sensitive to inhibitors of protein synthesis.
Le A; Ferrell GA; Dishon DS; Le QQ; Sifers RN
J Biol Chem; 1992 Jan; 267(2):1072-80. PubMed ID: 1530934
[TBL] [Abstract][Full Text] [Related]
15. Secretion of high-mannose-type alpha 1-proteinase inhibitor and alpha 1-acid glycoprotein by primary cultures of rat hepatocytes in the presence of the mannosidase I inhibitor 1-deoxymannojirimycin.
Gross V; Steube K; Tran-Thi TA; McDowell W; Schwarz RT; Decker K; Gerok W; Heinrich PC
Eur J Biochem; 1985 Jul; 150(1):41-6. PubMed ID: 3160588
[TBL] [Abstract][Full Text] [Related]
16. Intracellular association between UDP-glucose:glycoprotein glucosyltransferase and an incompletely folded variant of alpha1-antitrypsin.
Choudhury P; Liu Y; Bick RJ; Sifers RN
J Biol Chem; 1997 May; 272(20):13446-51. PubMed ID: 9148970
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the M1(Ala213) type of alpha 1-antitrypsin, a newly recognized, common "normal" alpha 1-antitrypsin haplotype.
Nukiwa T; Brantly M; Ogushi F; Fells G; Satoh K; Stier L; Courtney M; Crystal RG
Biochemistry; 1987 Aug; 26(17):5259-67. PubMed ID: 2890373
[TBL] [Abstract][Full Text] [Related]
18. Role of endoplasmic reticular calcium in oligosaccharide processing of alpha 1-antitrypsin.
Kuznetsov G; Brostrom MA; Brostrom CO
J Biol Chem; 1993 Jan; 268(3):2001-8. PubMed ID: 8380585
[TBL] [Abstract][Full Text] [Related]
19. A frameshift mutation results in a truncated alpha 1-antitrypsin that is retained within the rough endoplasmic reticulum.
Sifers RN; Brashears-Macatee S; Kidd VJ; Muensch H; Woo SL
J Biol Chem; 1988 May; 263(15):7330-5. PubMed ID: 3259232
[TBL] [Abstract][Full Text] [Related]
20. Molecular basis for defective secretion of the Z variant of human alpha-1-proteinase inhibitor: secretion of variants having altered potential for salt bridge formation between amino acids 290 and 342.
McCracken AA; Kruse KB; Brown JL
Mol Cell Biol; 1989 Apr; 9(4):1406-14. PubMed ID: 2786139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
